Professional
Added to YB: 2018-10-24
Pitch date: 2018-10-24
ARDX [bullish]
Ardelyx, Inc.
+77.43%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.
Market Cap
$1.4B
Pitch Price
$3.50
Price Target
N/A
Dividend
N/A
EV/EBITDA
-43.88
P/E
-24.60
EV/Sales
3.53
Sector
Biotechnology
Category
growth
Show full summary:
Appleseed Fund new holding: Ardelyx (ARDX)
ARDX: Pharma co developing tenapanor for IBS-C & hyperphosphatemia in ESRD, each $1B+ market. Currently $250M mkt cap, expect significant appreciation upon approval & commercialization for both indications given promising efficacy due to unique MOA.
Read full article (1 min)